Telos Capital Management Inc. Has $2.51 Million Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Telos Capital Management Inc. boosted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.6% in the 4th quarter, HoldingsChannel.com reports. The firm owned 27,816 shares of the exchange traded fund’s stock after acquiring an additional 1,710 shares during the quarter. Telos Capital Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $2,505,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. FMR LLC boosted its holdings in SPDR S&P Biotech ETF by 13.6% during the 3rd quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after acquiring an additional 830 shares during the last quarter. Ameritas Advisory Services LLC boosted its holdings in SPDR S&P Biotech ETF by 11.9% during the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock worth $962,000 after acquiring an additional 1,137 shares during the last quarter. Beaton Management Co. Inc. purchased a new position in SPDR S&P Biotech ETF during the 3rd quarter worth $212,000. Robinson Value Management Ltd. boosted its holdings in SPDR S&P Biotech ETF by 1.2% during the 3rd quarter. Robinson Value Management Ltd. now owns 13,452 shares of the exchange traded fund’s stock worth $1,329,000 after acquiring an additional 155 shares during the last quarter. Finally, Hollow Brook Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 4.9% during the 3rd quarter. Hollow Brook Wealth Management LLC now owns 21,669 shares of the exchange traded fund’s stock worth $2,141,000 after acquiring an additional 1,003 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI opened at $93.37 on Friday. The company has a market capitalization of $7.12 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The firm’s fifty day moving average price is $92.75 and its two-hundred day moving average price is $96.55. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.